COMPOSITION:
Glitz Tablet: Each tablet contains Gliclazide BP 80 mg.
PHARMACOLOGY:
Glitz (Gliclazide) is a second generation sulfonylurea drug that has hypoglycemic and potentially useful haemobiological properties. It stimulates the release of insulin from pancreatic beta cells by facilitating ca 2+ transport across the beta cell membranes and decreases hepatic glucose output.
No review yet